📆 Wednesday, August 19, 2026
—
🟢 Positive Ratings
Alnylam Pharma (ALNY) 🟢
Analyst: BMO Capital Markets initiates with “OUTPERFORM”.
Price Target: $318
Ascendis Pharma (ASND) 🟢
Analyst: BMO Capital Markets initiates with “OUTPERFORM”.
Price Target: $319
BioMarin Pharmaceutical (BMRN) 🟢
Analyst: BMO Capital Markets initiates with “OUTPERFORM”.
Price Target: $98
Subscribe to see more
